0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sleep Disorder Treatment Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-2T7295
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Sleep Disorder Treatment Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Sleep Disorder Treatment Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-2T7295
Report
September 2024
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sleep Disorder Treatment Drugs - Market Size

The global market for Sleep Disorder Treatment Drugs was estimated to be worth US$ 8856 million in 2023 and is forecast to a readjusted size of US$ 15720 million by 2030 with a CAGR of 8.4% during the forecast period 2024-2030

Sleep Disorder Treatment Drugs - Market

Sleep Disorder Treatment Drugs - Market

Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Treatment Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sleep Disorder Treatment Drugs by region & country, by Type, and by Application.
The Sleep Disorder Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Treatment Drugs.
Market Segmentation

Scope of Sleep Disorder Treatment Drugs - Market Report

Report Metric Details
Report Name Sleep Disorder Treatment Drugs - Market
Forecasted market size in 2030 US$ 15720 million
CAGR 8.4%
Forecasted years 2024 - 2030
Segment by Type:
  • Prescription-based Drugs
  • OTC Drugs
  • Herbal Drugs
Segment by Application
  • Hospitals
  • Clinics
  • Research Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Sanofi, Merck, GlaxoSmithKline, Koninklijke Philips, Takeda Pharmaceutical Company, Leva Pharmaceutical Industries, Cardinal Health, Becton Dickson and Company, Natus Medicalorporated, Mylan N.V., Teva Pharmaceutical Industries Ltd., Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.), Astellas Pharma, Athenex, Eisai, Evotec, Ferring International Center, Galenica, Heptares Therapeutics (Sosei Group Corporation), ZYDUS CADILA GROUP
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Sleep Disorder Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Sleep Disorder Treatment Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sleep Disorder Treatment Drugs - Market size in 2030?

Ans: The Sleep Disorder Treatment Drugs - Market size in 2030 will be US$ 15720 million.

Who are the main players in the Sleep Disorder Treatment Drugs - Market report?

Ans: The main players in the Sleep Disorder Treatment Drugs - Market are Pfizer, Sanofi, Merck, GlaxoSmithKline, Koninklijke Philips, Takeda Pharmaceutical Company, Leva Pharmaceutical Industries, Cardinal Health, Becton Dickson and Company, Natus Medicalorporated, Mylan N.V., Teva Pharmaceutical Industries Ltd., Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.), Astellas Pharma, Athenex, Eisai, Evotec, Ferring International Center, Galenica, Heptares Therapeutics (Sosei Group Corporation), ZYDUS CADILA GROUP

What are the Application segmentation covered in the Sleep Disorder Treatment Drugs - Market report?

Ans: The Applications covered in the Sleep Disorder Treatment Drugs - Market report are Hospitals, Clinics, Research Centers, Others

What are the Type segmentation covered in the Sleep Disorder Treatment Drugs - Market report?

Ans: The Types covered in the Sleep Disorder Treatment Drugs - Market report are Prescription-based Drugs, OTC Drugs, Herbal Drugs

1 Market Overview
1.1 Sleep Disorder Treatment Drugs Product Introduction
1.2 Global Sleep Disorder Treatment Drugs Market Size Forecast
1.2.1 Global Sleep Disorder Treatment Drugs Sales Value (2019-2030)
1.2.2 Global Sleep Disorder Treatment Drugs Sales Volume (2019-2030)
1.2.3 Global Sleep Disorder Treatment Drugs Sales Price (2019-2030)
1.3 Sleep Disorder Treatment Drugs Market Trends & Drivers
1.3.1 Sleep Disorder Treatment Drugs Industry Trends
1.3.2 Sleep Disorder Treatment Drugs Market Drivers & Opportunity
1.3.3 Sleep Disorder Treatment Drugs Market Challenges
1.3.4 Sleep Disorder Treatment Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sleep Disorder Treatment Drugs Players Revenue Ranking (2023)
2.2 Global Sleep Disorder Treatment Drugs Revenue by Company (2019-2024)
2.3 Global Sleep Disorder Treatment Drugs Players Sales Volume Ranking (2023)
2.4 Global Sleep Disorder Treatment Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Sleep Disorder Treatment Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Sleep Disorder Treatment Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Sleep Disorder Treatment Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sleep Disorder Treatment Drugs
2.9 Sleep Disorder Treatment Drugs Market Competitive Analysis
2.9.1 Sleep Disorder Treatment Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sleep Disorder Treatment Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Treatment Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prescription-based Drugs
3.1.2 OTC Drugs
3.1.3 Herbal Drugs
3.2 Global Sleep Disorder Treatment Drugs Sales Value by Type
3.2.1 Global Sleep Disorder Treatment Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sleep Disorder Treatment Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Sleep Disorder Treatment Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Sleep Disorder Treatment Drugs Sales Volume by Type
3.3.1 Global Sleep Disorder Treatment Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Sleep Disorder Treatment Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Sleep Disorder Treatment Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Sleep Disorder Treatment Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Research Centers
4.1.4 Others
4.2 Global Sleep Disorder Treatment Drugs Sales Value by Application
4.2.1 Global Sleep Disorder Treatment Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sleep Disorder Treatment Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Sleep Disorder Treatment Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Sleep Disorder Treatment Drugs Sales Volume by Application
4.3.1 Global Sleep Disorder Treatment Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sleep Disorder Treatment Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Sleep Disorder Treatment Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Sleep Disorder Treatment Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sleep Disorder Treatment Drugs Sales Value by Region
5.1.1 Global Sleep Disorder Treatment Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sleep Disorder Treatment Drugs Sales Value by Region (2019-2024)
5.1.3 Global Sleep Disorder Treatment Drugs Sales Value by Region (2025-2030)
5.1.4 Global Sleep Disorder Treatment Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Sleep Disorder Treatment Drugs Sales Volume by Region
5.2.1 Global Sleep Disorder Treatment Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sleep Disorder Treatment Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Sleep Disorder Treatment Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Sleep Disorder Treatment Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Sleep Disorder Treatment Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sleep Disorder Treatment Drugs Sales Value, 2019-2030
5.4.2 North America Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sleep Disorder Treatment Drugs Sales Value, 2019-2030
5.5.2 Europe Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sleep Disorder Treatment Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sleep Disorder Treatment Drugs Sales Value, 2019-2030
5.7.2 South America Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sleep Disorder Treatment Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value
6.2.1 Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sleep Disorder Treatment Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.3.2 United States Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.4.2 Europe Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.5.2 China Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.6.2 Japan Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.7.2 South Korea Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sleep Disorder Treatment Drugs Sales Value, 2019-2030
6.9.2 India Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sleep Disorder Treatment Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Sleep Disorder Treatment Drugs Product Offerings
7.1.5 Pfizer Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Information
7.2.2 Sanofi Introduction and Business Overview
7.2.3 Sanofi Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi Sleep Disorder Treatment Drugs Product Offerings
7.2.5 Sanofi Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Sleep Disorder Treatment Drugs Product Offerings
7.3.5 Merck Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Information
7.4.2 GlaxoSmithKline Introduction and Business Overview
7.4.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Product Offerings
7.4.5 GlaxoSmithKline Recent Development
7.5 Koninklijke Philips
7.5.1 Koninklijke Philips Company Information
7.5.2 Koninklijke Philips Introduction and Business Overview
7.5.3 Koninklijke Philips Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Koninklijke Philips Sleep Disorder Treatment Drugs Product Offerings
7.5.5 Koninklijke Philips Recent Development
7.6 Takeda Pharmaceutical Company
7.6.1 Takeda Pharmaceutical Company Company Information
7.6.2 Takeda Pharmaceutical Company Introduction and Business Overview
7.6.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Offerings
7.6.5 Takeda Pharmaceutical Company Recent Development
7.7 Leva Pharmaceutical Industries
7.7.1 Leva Pharmaceutical Industries Company Information
7.7.2 Leva Pharmaceutical Industries Introduction and Business Overview
7.7.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Offerings
7.7.5 Leva Pharmaceutical Industries Recent Development
7.8 Cardinal Health
7.8.1 Cardinal Health Company Information
7.8.2 Cardinal Health Introduction and Business Overview
7.8.3 Cardinal Health Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cardinal Health Sleep Disorder Treatment Drugs Product Offerings
7.8.5 Cardinal Health Recent Development
7.9 Becton Dickson and Company
7.9.1 Becton Dickson and Company Company Information
7.9.2 Becton Dickson and Company Introduction and Business Overview
7.9.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Product Offerings
7.9.5 Becton Dickson and Company Recent Development
7.10 Natus Medicalorporated
7.10.1 Natus Medicalorporated Company Information
7.10.2 Natus Medicalorporated Introduction and Business Overview
7.10.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Product Offerings
7.10.5 Natus Medicalorporated Recent Development
7.11 Mylan N.V.
7.11.1 Mylan N.V. Company Information
7.11.2 Mylan N.V. Introduction and Business Overview
7.11.3 Mylan N.V. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Mylan N.V. Sleep Disorder Treatment Drugs Product Offerings
7.11.5 Mylan N.V. Recent Development
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Company Information
7.12.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
7.12.3 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Offerings
7.12.5 Teva Pharmaceutical Industries Ltd. Recent Development
7.13 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.)
7.13.1 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
7.13.2 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Introduction and Business Overview
7.13.3 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Offerings
7.13.5 Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development
7.14 Astellas Pharma
7.14.1 Astellas Pharma Company Information
7.14.2 Astellas Pharma Introduction and Business Overview
7.14.3 Astellas Pharma Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Astellas Pharma Sleep Disorder Treatment Drugs Product Offerings
7.14.5 Astellas Pharma Recent Development
7.15 Athenex
7.15.1 Athenex Company Information
7.15.2 Athenex Introduction and Business Overview
7.15.3 Athenex Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Athenex Sleep Disorder Treatment Drugs Product Offerings
7.15.5 Athenex Recent Development
7.16 Eisai
7.16.1 Eisai Company Information
7.16.2 Eisai Introduction and Business Overview
7.16.3 Eisai Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Eisai Sleep Disorder Treatment Drugs Product Offerings
7.16.5 Eisai Recent Development
7.17 Evotec
7.17.1 Evotec Company Information
7.17.2 Evotec Introduction and Business Overview
7.17.3 Evotec Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Evotec Sleep Disorder Treatment Drugs Product Offerings
7.17.5 Evotec Recent Development
7.18 Ferring International Center
7.18.1 Ferring International Center Company Information
7.18.2 Ferring International Center Introduction and Business Overview
7.18.3 Ferring International Center Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Ferring International Center Sleep Disorder Treatment Drugs Product Offerings
7.18.5 Ferring International Center Recent Development
7.19 Galenica
7.19.1 Galenica Company Information
7.19.2 Galenica Introduction and Business Overview
7.19.3 Galenica Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Galenica Sleep Disorder Treatment Drugs Product Offerings
7.19.5 Galenica Recent Development
7.20 Heptares Therapeutics (Sosei Group Corporation)
7.20.1 Heptares Therapeutics (Sosei Group Corporation) Company Information
7.20.2 Heptares Therapeutics (Sosei Group Corporation) Introduction and Business Overview
7.20.3 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Offerings
7.20.5 Heptares Therapeutics (Sosei Group Corporation) Recent Development
7.21 ZYDUS CADILA GROUP
7.21.1 ZYDUS CADILA GROUP Company Information
7.21.2 ZYDUS CADILA GROUP Introduction and Business Overview
7.21.3 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)
7.21.4 ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Offerings
7.21.5 ZYDUS CADILA GROUP Recent Development
8 Industry Chain Analysis
8.1 Sleep Disorder Treatment Drugs Industrial Chain
8.2 Sleep Disorder Treatment Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sleep Disorder Treatment Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Sleep Disorder Treatment Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sleep Disorder Treatment Drugs Market Trends
    Table 2. Sleep Disorder Treatment Drugs Market Drivers & Opportunity
    Table 3. Sleep Disorder Treatment Drugs Market Challenges
    Table 4. Sleep Disorder Treatment Drugs Market Restraints
    Table 5. Global Sleep Disorder Treatment Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sleep Disorder Treatment Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Sleep Disorder Treatment Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Sleep Disorder Treatment Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Sleep Disorder Treatment Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Sleep Disorder Treatment Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Sleep Disorder Treatment Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Sleep Disorder Treatment Drugs
    Table 13. Global Sleep Disorder Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep Disorder Treatment Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Sleep Disorder Treatment Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Sleep Disorder Treatment Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Sleep Disorder Treatment Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Sleep Disorder Treatment Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Sleep Disorder Treatment Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Sleep Disorder Treatment Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Sleep Disorder Treatment Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Sleep Disorder Treatment Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Sleep Disorder Treatment Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Sleep Disorder Treatment Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Sleep Disorder Treatment Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Sleep Disorder Treatment Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Sleep Disorder Treatment Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Sleep Disorder Treatment Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Sleep Disorder Treatment Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Sleep Disorder Treatment Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Sleep Disorder Treatment Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Sleep Disorder Treatment Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Sleep Disorder Treatment Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Sleep Disorder Treatment Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Sleep Disorder Treatment Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Sleep Disorder Treatment Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Sleep Disorder Treatment Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Sleep Disorder Treatment Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Sleep Disorder Treatment Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Sleep Disorder Treatment Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Sleep Disorder Treatment Drugs Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Sanofi Company Information
    Table 63. Sanofi Introduction and Business Overview
    Table 64. Sanofi Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Sleep Disorder Treatment Drugs Product Offerings
    Table 66. Sanofi Recent Development
    Table 67. Merck Company Information
    Table 68. Merck Introduction and Business Overview
    Table 69. Merck Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Merck Sleep Disorder Treatment Drugs Product Offerings
    Table 71. Merck Recent Development
    Table 72. GlaxoSmithKline Company Information
    Table 73. GlaxoSmithKline Introduction and Business Overview
    Table 74. GlaxoSmithKline Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. GlaxoSmithKline Sleep Disorder Treatment Drugs Product Offerings
    Table 76. GlaxoSmithKline Recent Development
    Table 77. Koninklijke Philips Company Information
    Table 78. Koninklijke Philips Introduction and Business Overview
    Table 79. Koninklijke Philips Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Koninklijke Philips Sleep Disorder Treatment Drugs Product Offerings
    Table 81. Koninklijke Philips Recent Development
    Table 82. Takeda Pharmaceutical Company Company Information
    Table 83. Takeda Pharmaceutical Company Introduction and Business Overview
    Table 84. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Offerings
    Table 86. Takeda Pharmaceutical Company Recent Development
    Table 87. Leva Pharmaceutical Industries Company Information
    Table 88. Leva Pharmaceutical Industries Introduction and Business Overview
    Table 89. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Offerings
    Table 91. Leva Pharmaceutical Industries Recent Development
    Table 92. Cardinal Health Company Information
    Table 93. Cardinal Health Introduction and Business Overview
    Table 94. Cardinal Health Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Cardinal Health Sleep Disorder Treatment Drugs Product Offerings
    Table 96. Cardinal Health Recent Development
    Table 97. Becton Dickson and Company Company Information
    Table 98. Becton Dickson and Company Introduction and Business Overview
    Table 99. Becton Dickson and Company Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Becton Dickson and Company Sleep Disorder Treatment Drugs Product Offerings
    Table 101. Becton Dickson and Company Recent Development
    Table 102. Natus Medicalorporated Company Information
    Table 103. Natus Medicalorporated Introduction and Business Overview
    Table 104. Natus Medicalorporated Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Natus Medicalorporated Sleep Disorder Treatment Drugs Product Offerings
    Table 106. Natus Medicalorporated Recent Development
    Table 107. Mylan N.V. Company Information
    Table 108. Mylan N.V. Introduction and Business Overview
    Table 109. Mylan N.V. Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Mylan N.V. Sleep Disorder Treatment Drugs Product Offerings
    Table 111. Mylan N.V. Recent Development
    Table 112. Teva Pharmaceutical Industries Ltd. Company Information
    Table 113. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 114. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Teva Pharmaceutical Industries Ltd. Sleep Disorder Treatment Drugs Product Offerings
    Table 116. Teva Pharmaceutical Industries Ltd. Recent Development
    Table 117. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Company Information
    Table 118. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Introduction and Business Overview
    Table 119. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Sleep Disorder Treatment Drugs Product Offerings
    Table 121. Alexza Pharmaceuticals (Ferrer Therapeutics, Inc.) Recent Development
    Table 122. Astellas Pharma Company Information
    Table 123. Astellas Pharma Introduction and Business Overview
    Table 124. Astellas Pharma Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Astellas Pharma Sleep Disorder Treatment Drugs Product Offerings
    Table 126. Astellas Pharma Recent Development
    Table 127. Athenex Company Information
    Table 128. Athenex Introduction and Business Overview
    Table 129. Athenex Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Athenex Sleep Disorder Treatment Drugs Product Offerings
    Table 131. Athenex Recent Development
    Table 132. Eisai Company Information
    Table 133. Eisai Introduction and Business Overview
    Table 134. Eisai Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 135. Eisai Sleep Disorder Treatment Drugs Product Offerings
    Table 136. Eisai Recent Development
    Table 137. Evotec Company Information
    Table 138. Evotec Introduction and Business Overview
    Table 139. Evotec Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 140. Evotec Sleep Disorder Treatment Drugs Product Offerings
    Table 141. Evotec Recent Development
    Table 142. Ferring International Center Company Information
    Table 143. Ferring International Center Introduction and Business Overview
    Table 144. Ferring International Center Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 145. Ferring International Center Sleep Disorder Treatment Drugs Product Offerings
    Table 146. Ferring International Center Recent Development
    Table 147. Galenica Company Information
    Table 148. Galenica Introduction and Business Overview
    Table 149. Galenica Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 150. Galenica Sleep Disorder Treatment Drugs Product Offerings
    Table 151. Galenica Recent Development
    Table 152. Heptares Therapeutics (Sosei Group Corporation) Company Information
    Table 153. Heptares Therapeutics (Sosei Group Corporation) Introduction and Business Overview
    Table 154. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 155. Heptares Therapeutics (Sosei Group Corporation) Sleep Disorder Treatment Drugs Product Offerings
    Table 156. Heptares Therapeutics (Sosei Group Corporation) Recent Development
    Table 157. ZYDUS CADILA GROUP Company Information
    Table 158. ZYDUS CADILA GROUP Introduction and Business Overview
    Table 159. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 160. ZYDUS CADILA GROUP Sleep Disorder Treatment Drugs Product Offerings
    Table 161. ZYDUS CADILA GROUP Recent Development
    Table 162. Key Raw Materials Lists
    Table 163. Raw Materials Key Suppliers Lists
    Table 164. Sleep Disorder Treatment Drugs Downstream Customers
    Table 165. Sleep Disorder Treatment Drugs Distributors List
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sleep Disorder Treatment Drugs Product Picture
    Figure 2. Global Sleep Disorder Treatment Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Sleep Disorder Treatment Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Sleep Disorder Treatment Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Sleep Disorder Treatment Drugs Report Years Considered
    Figure 7. Global Sleep Disorder Treatment Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Sleep Disorder Treatment Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sleep Disorder Treatment Drugs Revenue in 2023
    Figure 10. Sleep Disorder Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Prescription-based Drugs Picture
    Figure 12. OTC Drugs Picture
    Figure 13. Herbal Drugs Picture
    Figure 14. Global Sleep Disorder Treatment Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Sleep Disorder Treatment Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Sleep Disorder Treatment Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Sleep Disorder Treatment Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Sleep Disorder Treatment Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Research Centers
    Figure 22. Product Picture of Others
    Figure 23. Global Sleep Disorder Treatment Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Sleep Disorder Treatment Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Sleep Disorder Treatment Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Sleep Disorder Treatment Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Sleep Disorder Treatment Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Sleep Disorder Treatment Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Sleep Disorder Treatment Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Sleep Disorder Treatment Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Sleep Disorder Treatment Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Sleep Disorder Treatment Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Sleep Disorder Treatment Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Sleep Disorder Treatment Drugs Industrial Chain
    Figure 62. Sleep Disorder Treatment Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS